325 related articles for article (PubMed ID: 37190171)
1. Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment.
Zhang S; Shen T; Zeng Y
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190171
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
3. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
4. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
Zhang J; Huang L; Ge G; Hu K
Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
Niu Y; Chen J; Qiao Y
Front Immunol; 2022; 13():836223. PubMed ID: 35140725
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in prostate cancer: clinical implications.
Conteduca V; Hess J; Yamada Y; Ku SY; Beltran H
Transl Androl Urol; 2021 Jul; 10(7):3104-3116. PubMed ID: 34430414
[TBL] [Abstract][Full Text] [Related]
8. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate.
Deeb KK; Luo W; Karpf AR; Omilian AR; Bshara W; Tian L; Tangrea MA; Morrison CD; Johnson CS; Trump DL
Epigenetics; 2011 Aug; 6(8):994-1000. PubMed ID: 21725204
[TBL] [Abstract][Full Text] [Related]
9. The role of epigenetic modifications in Colorectal Cancer Metastasis.
Su R; Wu X; Tao L; Wang C
Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
[TBL] [Abstract][Full Text] [Related]
10. Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation.
Pandareesh MD; Kameshwar VH; Byrappa K
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):253-267. PubMed ID: 32682386
[TBL] [Abstract][Full Text] [Related]
11. Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma.
Kanwore K; Kanwore K; Adzika GK; Abiola AA; Guo X; Kambey PA; Xia Y; Gao D
Front Immunol; 2022; 13():831636. PubMed ID: 35392088
[TBL] [Abstract][Full Text] [Related]
12. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.
Xie HY; Shao ZM; Li DQ
Chin J Cancer; 2017 Mar; 36(1):36. PubMed ID: 28356139
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
15. The Aged Microenvironment Influences the Tumorigenic Potential of Malignant Prostate Epithelial Cells.
Bianchi-Frias D; Damodarasamy M; Hernandez SA; Gil da Costa RM; Vakar-Lopez F; Coleman IM; Reed MJ; Nelson PS
Mol Cancer Res; 2019 Jan; 17(1):321-331. PubMed ID: 30224545
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Alterations in Triple-Negative Breast Cancer-The Critical Role of Extracellular Matrix.
Zolota V; Tzelepi V; Piperigkou Z; Kourea H; Papakonstantinou E; Argentou ΜI; Karamanos NK
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572395
[TBL] [Abstract][Full Text] [Related]
17. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Bianco-Miotto T; Chiam K; Buchanan G; Jindal S; Day TK; Thomas M; Pickering MA; O'Loughlin MA; Ryan NK; Raymond WA; Horvath LG; Kench JG; Stricker PD; Marshall VR; Sutherland RL; Henshall SM; Gerald WL; Scher HI; Risbridger GP; Clements JA; Butler LM; Tilley WD; Horsfall DJ; Ricciardelli C;
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2611-22. PubMed ID: 20841388
[TBL] [Abstract][Full Text] [Related]
18. Reshaping Prostate Tumor Microenvironment To Suppress Metastasis
Lang J; Zhao X; Qi Y; Zhang Y; Han X; Ding Y; Guan J; Ji T; Zhao Y; Nie G
ACS Nano; 2019 Nov; 13(11):12357-12371. PubMed ID: 31545587
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
Sabherwal Y; Mahajan N; Zhang M
Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
